EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes

Amalia Kotsifaki, Georgia Kalouda, Efthymios Karalexis, Martha Stathaki iD, Georgios Metaxas, Athanasios Armakolas

International Journal of Molecular Sciences · 29.11.2025 · 26 (23) · 11599

DOI: 10.3390/ijms262311599 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.11.2025. Verfasst von Amalia Kotsifaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is increasingly recognized as a heterogeneous disease, with complexity that extends beyond the classical luminal A/B, HER2-enriched, and triple-negative framework. Advances in molecular and functional profiling have uncovered emerging subpopulations, including HER2-low, claudin-low, BRCA-deficient (“BRCAness”), and refined TNBC subsets, such as luminal AR (LAR) and basal-like immune variants, that extend beyond traditional taxonomies. These novel classifications provide additional resolutions, offering both prognostic insight and therapeutic opportunities. In this comprehensive review, we integrate evidence from genomic, epigenetic, proteomic, immune-related, and liquid biopsy biomarkers, underscoring how they define the biology of these subgroups and predict responses to targeted therapies, such as antibody–drug conjugates, PARP inhibitors, and immune checkpoint blockade. We further highlight the role of the tumor microenvironment (TME) and intratumoral heterogeneity in shaping these entities. Collectively, recognition of emerging subtypes as clinically actionable groups represents a paradigm shift from static receptor-based models to dynamic, biomarker-driven frameworks that refine prognosis, enable patient stratification, and support precision oncology in aggressive BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleTumor MicroenvironmentBiomarkers, TumorPrognosis

Stichwörter der Autor:innen

BRCAnessHER2-lowbreast cancer subtypesclaudin-lowemerging populationsfunctional heterogeneityintratumoral heterogeneityprecision oncologyprognostic biomarkerstumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Surgery, Elena Venizelou Hospital, 11521 Athens, Greece.

ORCID-Profile: Martha Stathaki

Zitieren

APA

Kotsifaki, A., Kalouda, G., Karalexis, E., Stathaki, M., Metaxas, G., & Armakolas, A. (2025). Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes. International Journal of Molecular Sciences, 26(23), 11599. https://doi.org/10.3390/ijms262311599

Vancouver

Kotsifaki A, Kalouda G, Karalexis E, Stathaki M, Metaxas G, Armakolas A. Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes. International Journal of Molecular Sciences. 2025;26(23):11599. doi:10.3390/ijms262311599

BibTeX
@article{Kotsifaki2025,
  author = {Kotsifaki, Amalia and Kalouda, Georgia and Karalexis, Efthymios and Stathaki, Martha and Metaxas, Georgios and Armakolas, Athanasios},
  title = {Emerging Breast Cancer Subpopulations: Functional Heterogeneity Beyond the Classical Subtypes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {23},
  pages = {11599},
  doi = {10.3390/ijms262311599}
}
Kostenlos starten →